These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Probing Antibacterial and Anticancer Potential of Safdar S; Shamim S; Khan M; Imran A; Khan MA; Ali Q; Han S Molecules; 2023 Dec; 28(24):. PubMed ID: 38138636 [TBL] [Abstract][Full Text] [Related]
10. Virtual Screening and ADMET Prediction to Uncover the Potency of Flavonoids from Genus Akili AWR; Hardianto A; Latip J; Permana A; Herlina T Molecules; 2023 Dec; 28(24):. PubMed ID: 38138500 [TBL] [Abstract][Full Text] [Related]
12. Propionibacteria as promising tools for the production of pro-bioactive scotta: a proof-of-concept study. Coronas R; Zara G; Gallo A; Rocchetti G; Lapris M; Petretto GL; Zara S; Fancello F; Mannazzu I Front Microbiol; 2023; 14():1223741. PubMed ID: 37588883 [TBL] [Abstract][Full Text] [Related]
13. Bactericidal activity of silver nanoparticles in drug-resistant bacteria. Chapa González C; González García LI; Burciaga Jurado LG; Carrillo Castillo A Braz J Microbiol; 2023 Jun; 54(2):691-701. PubMed ID: 37131105 [TBL] [Abstract][Full Text] [Related]
14. DNA Gyrase as a Target for Quinolones. Spencer AC; Panda SS Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830908 [TBL] [Abstract][Full Text] [Related]
15. [The history of the development and changes of quinolone antibacterial agents]. Takahashi H; Hayakawa I; Akimoto T Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768 [TBL] [Abstract][Full Text] [Related]
17. The Current Case of Quinolones: Synthetic Approaches and Antibacterial Activity. Naeem A; Badshah SL; Muska M; Ahmad N; Khan K Molecules; 2016 Mar; 21(4):268. PubMed ID: 27043501 [TBL] [Abstract][Full Text] [Related]